Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells
Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells. Shamri R, Dubois G, Erpenbeck VJ, Mankuta D, Sandham DA, Levi-Schaffer F. Clin Exp Allergy. 2019 Feb;49(2):255-257. doi: 10.1111/cea.13304. Epub 2018 Nov 25. PMID: 30379368
On Wednesday, the 22nd of January, 2025, there will a webinar, jointly hosted by the International Eosinophil Society (IES) and European Mast Cell and Basophil Research
This intensive mast cell training school is designed to provide young investigators (under 35 years old), with or without mast cell background, with the means to
Save the date : the next European Mast Cell and Basophil Research Network (EMBRN) meeting will take place in Vienna, Austria, from June 10 to 12 2026.